首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1316239

全球經橈動脈入路設備市場 - 2023-2030 年

Global Transradial Access Device Market - 2023-2030

出版日期: 2023年07月27日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年，全球經橈動脈入路設備市場規模達到20 億美元，預計到2030 年將達到34 億美元，2023-2030 年的年複合成長率為7.4%。

經橈動脈技術是進行冠狀動脈和周邊血管造影和介入治療的一種實用微創方法。經橈動脈導管術通常是一種更安全、更具成本效益、對患者更友好的手術。

市場動態

老年人口成長將推動市場成長

推動經橈動脈入路裝置市場發展的主要因素之一是老年人口的不斷擴大。相當一部分老年人患有心臟中風並接受心血管手術。在這些疾病中，充血性心力衰竭、冠狀動脈疾病、高血壓和心房顫動最為嚴重。

例如，根據美國心臟病協會期刊的估計，在60 歲及以上的老年人中，55% 至98% 至少患有兩種慢性疾病。因此，老年人口的增加推動了市場的成長。

心血管疾病發病率上升推動市場成長

周邊血管疾病等慢性疾病發病率的增加將推動市場成長。心血管疾病是常發疾病。中風、外周動脈疾病和主動脈疾病事件經常發生。例如，根據《紐約政府報告》，每年約有80.5 萬美國人心臟病發作。因此，心血管疾病發病率的增加將擴大市場成長。

設備的副作用將阻礙市場成長

經橈動脈入路設備的副作用會導致市場成長下降。使用經橈動脈入路器械會產生許多副作用。副作用包括

血管併發症。例如，經橈動脈入路後最常見的併發症是大約5%的橈動脈閉塞風險。

如果艾倫測試符合標準，這種併發症在臨床上並不嚴重。掌弓不完整和艾倫測試異常的患者在橈動脈閉塞後可能會出現手部缺血症狀。因此，相關副作用會阻礙市場成長。

COVID-19 影響分析

COVID-19 大流行對經橈動脈入路裝置市場產生了重大影響，給許多國家帶來了前所未有的挑戰。與心血管疾病相關的治療程序延遲和手術推遲對經橈動脈入路裝置的使用造成了影響。這導致經橈動脈裝置市場的成長大幅下降。

Market Overview

Global Transradial Access Device Market reached US$ 2.0 billion in 2022 and is expected to reach US$ 3.4 billion by 2030 growing with a CAGR of 7.4% during the forecast period 2023-2030.

The transradial technique is a practical, minimally invasive approach to performing coronary and peripheral angiograms and interventions. Transradial catheterization is typically a safer, more cost-effective, and patient-friendly procedure.

Market Dynamics

Growing Geriatric Population will Drive the Growth of the Market

One of the primary driving factors that would boost the tranradial access device market is the expanding older population. A considerable proportion of the elderly population suffers from heart strokes and undergoes cardiovascular surgeries. Among these diseases, congestive heart failure, coronary artery diseases, hypertension, and atrial fibrillation have the greatest significance.

For instance, according to AHA Journals, it has been estimated that between 55% and 98% of older adults aged 60 years and over have at least 2 chronic diseases. Thus, increase in the population of older people is driving the market growth.

Increase in the Incidence of Cardiovascular Diseases is Driving the Market Growth

Increased disease incidences of chronic diseases, such as peripheral vascular diseases, will fuel market growth. Cardiovascular diseases are frequently occurring diseases. Stroke, peripheral arterial disease, and aortic disease events frequently occur. For instance, according to New York Govt., every year, about 805,000 Americans have a heart attack. Thus increase in the incidence of cardiovascular diseases will expand the market growth.

Side Effects Associated with the Devices Will Hamper the Market Growth

The side effects associated with transradial access devices can cause a decline in market growth. There are a number of side effects that are resulted due to the use of transradial access devices. The

use of transradial devices can lead to vascular complications. For instance, the most frequent complication after transradial access is about a 5% risk of radial artery occlusion.

This is a clinically insignificant complication if the Allen test is standard. Patients with incomplete palmar arch and abnormal Allen test may have symptoms of hand ischemia after radial artery occlusion. Thus, the side effects associated can hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a significant influence on the transradial access device market, posing unprecedented challenges to many countries. Delay in the treatment procedure and postponement of surgeries related to cardiovascular diseases has shown the impact on using the transradial access device. This resulted in a significant decline in the transradial device market growth.

Segment Analysis

The transradial access device market is segmented based on product type, application, and end user.

The Guidewires Segment Accounts for 27.3% the of Transradial Access Device Market Share

Guidewires are used during minimally invasive interventional procedures to traverse in the vascular system and access the desired position. Computer models are increasingly being used to predict the behavior of these instruments. Ace Angiography Guide Wires are hydrophilic guidewires and are used for percutaneous vessel entry to facilitate the subsequent introduction of an intravascular device. This device is supplied sterile in a peel-open pouch.

The purpose of a guidewire is to gain access to the blood vessels using a minimally invasive technique. For instance, according to CDC, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Thus, an increase in the number of coronary heart diseases expands the market growth. Thus, the cardiovascular disease segment holds the leading position in the market share.

Geographical Analysis

Asia Pacific accounted for Approximately 23.4% of the Market Share Owing to the Increasing Geriatric Population.

During the forecast period, Asia-Pacific is expected to grow at the fastest rate because of the growing geriatric population in nations such as India and China, the region has become a hotspot for cardiovascular disorders, increasing demand for coronary therapies and fueling company expansion. As well as an increase in the number of cases of cardiovascular disease and technical advancement in this region.

For instance, according to NLM, India has one of the world's highest burdens of cardiovascular disease (CVD). The annual number of CVD fatalities in India is expected to climb from 2.26 million in 1990 to 4.77 million in 2020. Over the last several decades, estimates of the prevalence of coronary heart disease in India have ranged from 1.6% to 7.4% in rural populations and from 1% to 13.2% in urban populations. As a result, diseases are on the rise, which contributes to the region's growth.

Competitive Landscape

The major global players in the transradial access device market include: AmecoMedical; BD; Angiodynamics, Inc.; BostonScientific Corporation; Edward Lifesciences Corporation; Teleflex Incorporated; Merit Medical Systems; Medtronic; Nipro Medical Corporation; Oscor Inc. among others.

Why Purchase the Report?

To visualize the transradial access device market segmentation based on product type, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of transradial access device market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The transradial access device market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the number of coronary artery procedures
  - 4.1.1.2. Increasing awareness among people around the world
- 4.1.2. Restraints
  - 4.1.2.1. Complications Associated with the Devices
- 4.1.3. Opportunity
  - 4.1.3.1. Continued research and developments and training initiatives
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine Impact Analysis

8. By Product Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.1.2. Market Attractiveness Index, By Product Type
8.2. Catheters
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Guidewires
8.4. Sheaths
8.5. Others

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Drug Administration
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Blood Transfusion
9.4. Diagnostics
9.5. Others

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty clinics
10.4. Ambulatory surgical centers
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.6.1. U.S.
  - 11.2.6.2. Canada
  - 11.2.6.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.6.1. Germany
  - 11.3.6.2. U.K.
  - 11.3.6.3. France
  - 11.3.6.4. Spain
  - 11.3.6.5. Italy
  - 11.3.6.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.6.1. Brazil
  - 11.4.6.2. Argentina
  - 11.4.6.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.6.1. China
  - 11.5.6.2. India
  - 11.5.6.3. Japan
  - 11.5.6.4. Australia
  - 11.5.6.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Ameco Medical
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. BD
13.3. Angiodynamics, Inc.
13.4. Boston Scientific Corporation
13.5. Edward Lifesciences Corporation
13.6. Teleflex Incorporated
13.7. Merit Medical Systems
13.8. Medtronic
13.9. Nipro Medical Corporation
13.10. Oscor Inc.

LIST NOT EXHAUSTIVE